Esprit BTK Post-Approval Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 200 participants.
Also called NCT06656364
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT06656364
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Hong Kong SAR China, New Zealand, United Arab Emirates
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06656364. Allocation not applicable; no masking; primary purpose treatment. Start 2024-10-21 (actual); primary completion 2027-04-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Esprit BTK Post-Approval Study
- Acronym
- EspritBTKPAS
- Condition
- Chronic Limb-Threatening Ischemia
- Intervention (Device)
- Esprit BTK System
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct06656364- Content hash
58ac242407d49a8bbc93c3e73dbd0a4bfeac783c0ced535e987d7c67122beaea